Ethic Inc. Increases Stake in Xylem Inc. $XYL

Ethic Inc. boosted its stake in Xylem Inc. (NYSE:XYL) by 54.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 67,056 shares of the industrial products company’s stock after buying an additional 23,556 shares during the quarter. Ethic Inc.’s holdings in Xylem were worth $9,891,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in XYL. AFG Fiduciary Services Limited Partnership purchased a new position in shares of Xylem in the 2nd quarter valued at approximately $275,000. IFM Investors Pty Ltd raised its holdings in Xylem by 11.6% in the second quarter. IFM Investors Pty Ltd now owns 54,073 shares of the industrial products company’s stock worth $6,995,000 after purchasing an additional 5,617 shares in the last quarter. Impax Asset Management Group plc lifted its position in Xylem by 13.7% during the second quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock valued at $709,183,000 after buying an additional 663,191 shares during the period. XXEC Inc. lifted its position in Xylem by 66.0% during the second quarter. XXEC Inc. now owns 33,698 shares of the industrial products company’s stock valued at $4,359,000 after buying an additional 13,404 shares during the period. Finally, Acadian Asset Management LLC bought a new stake in shares of Xylem during the 2nd quarter valued at $20,361,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Insider Activity

In other news, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares of the company’s stock, valued at $4,770,000. This trade represents a 25.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.27% of the stock is currently owned by company insiders.

Xylem Trading Down 0.3%

NYSE:XYL opened at $138.42 on Tuesday. The stock has a market cap of $33.70 billion, a price-to-earnings ratio of 35.58, a PEG ratio of 2.15 and a beta of 1.18. The company has a quick ratio of 1.50, a current ratio of 1.96 and a debt-to-equity ratio of 0.17. The company’s 50 day moving average price is $143.03 and its 200-day moving average price is $140.02. Xylem Inc. has a 52 week low of $100.47 and a 52 week high of $154.27.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company had revenue of $2.27 billion during the quarter, compared to analyst estimates of $2.22 billion. During the same period in the previous year, the business earned $1.11 EPS. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, equities research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Tuesday, November 25th. This represents a $1.60 annualized dividend and a dividend yield of 1.2%. Xylem’s dividend payout ratio (DPR) is 41.13%.

Analyst Ratings Changes

Several research analysts recently issued reports on XYL shares. Zacks Research lowered shares of Xylem from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Royal Bank Of Canada upped their price objective on shares of Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Wall Street Zen downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research note on Saturday. UBS Group boosted their price target on Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Finally, Robert W. Baird set a $178.00 price target on Xylem in a research note on Wednesday, October 29th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $167.40.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.